Hassan Motamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hassan Motamed has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Kambiz Masoumi
Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
8 shared publications - Arash Forouzan
Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
7 shared publications Arash Forouzan
Emergency Medicine Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 shared publicationsMohammadreza Maleki Verki
Emergency Medicine Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 shared publications- Ali Delirrooyfard
Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 shared publications Alireza Majidi
Department of Emergency Medicine, Shahid Beheshti Medical University, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (2) , e171672
Chronic Diseases in Disasters: A Dilemma for Health Systems and the Role of Emergency Medicine During War and Crisis
- 30 May 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (2) , e171672
Open AccessChronic Diseases in Disasters: A Dilemma for Health Systems and the Role of Emergency Medicine During War and Crisis
- Open Access
- 12 February 2026
- Published by Springer Nature in Research Square
Is there any agreed cut off point for serum HbA1c level to be considered as a protective burden for Ischemic Cerebrovascular Accidents occurrence in Diabetics?
Introduction Diabetes mellitus is one of the most common chronic diseases worldwide. It associated with a higher risk of cardiovascular complications, including cerebrovascular accidents. Studies show that people with diabetes have twice the risk of stroke compared to those without diabetes. The high rates of stroke-related morbidity result in a substantial economic burden. In patients with type 2 diabetes, maintaining HbA1c about 1 percentage point lower with intensive glucose control for several years leads to lasting clinical benefits. The current study aims to determine, despite the potential role of diabetes mellitus in cerebrovascular events (ischemic stroke), which HbA1c cut-off increased the risk of cerebrovascular events and which cut-off is safe in terms of cerebrovascular events. This study had been designed with a fucose on HBA1c cut-off point determination compatible with significant increased risk and incidence for ischemic cerebrovascular attacks in diabetes. Methods and Materials Diabetic patients of more than 18 years old who had clinical symptoms and signs of an acute ischemic stroke in recent 6 hours which have been confirmed subsequently by cranial neuroimaging of Computed Tomography Scan or Magnetic Resonance Imaging by an emergency medicine specialist or a neurologist, were included in the study, while diabetic patients with no history of stroke were considered the control group. Serum HbA1c level has been evaluated for both groups. Data has been analyzed to evaluate correlation of serum HbA1c level cut-off with risk of cerebrovascular ischemic stroke in diabetics. Sample size with a power of 80% was calculated 62 diabetic patients with acute ischemic stroke and 62 diabetic patients without stroke as control group. Results Demographic and baseline characteristics of both the case and control groups were compared. There were no significant differences between the two groups in age, sex, IHD, HTN, DLP, and smoking. We had 62 diabetic patients with CVA with a mean age of 64.16±12.43 and 62 diabetic patients without CVA with a mean age of 63.37±6.82. Regarding comparing the HbA1C average between patients with and without CVA, the mean in patients with CVA was 8.21 ±1.70, while in patients without CVA it was 7.56 ±1.28 that which was significantly higher in CVA (p-value <0.02). Using logistic regression, the odds ratio (OR) with a 95% confidence interval was calculated as 1.34 (1.05,1.71). The predictive value of HbA1c for an increase in the risk of CVA occurrence was determined by ROC curve plotting; an AUC with 95% CI (0.516,0.694) was calculated 0.608 (p-value<0.036). Youden index for optimal HbA1c range for CVA risk, considering sensitivity as 69.35 and specificity as 35.48; showed a HbA1c cut-off point of 6.8. Discussion Several studies have assessed differences in mean HbA1c levels between individuals with and without stroke, but the findings have been inconsistent. In addition, only a few studies have demonstrated the predictive value of HbA1c for stroke or identified the specific levels that put patients at higher risk. In this study, we show that the HbA1c mean in diabetic patients with stroke was significantly higher than diabetic patients without stroke. Having diabetes substantially increased the odds of ischemic stroke roughly in the range of 30%to 100% higher risk after adjusting for other vascular risk factors. In a trial, patients with HbA1c8.6% faced increased risk, indicating that lifestyle intervention’s vascular benefits including ischemic stroke prevention are limited to patients with relatively well controlled baseline glycemia. Our study shows that higher HbA1c levels are associated with a raised risk of stroke. Recognizing the HbA1c level that puts patients at higher risk of stroke can help clinicians focus on better glycemic control. Therefore, keeping HbA1c within safe ranges may play an important role in preventing strokes. Conclusion Elevated HbA1c levels exceeding 8% among diabetic patients appear to significantly cause prominent elevation in ischemic stroke occurrence risk, whereas maintaining HbA1c within the 6.8 to 7.0% range accompany with less potential risk for ischemic stroke events.
- 12 February 2026
- Published by Springer Nature in Research Square
Open AccessIs there any agreed cut off point for serum HbA1c level to be considered as a protective burden for Ischemic Cerebrovascular Accidents occurrence in Diabetics?
Introduction Diabetes mellitus is one of the most common chronic diseases worldwide. It associated with a higher risk of cardiovascular complications, including cerebrovascular accidents. Studies show that people with diabetes have twice the risk of stroke compared to those without diabetes. The high rates of stroke-related morbidity result in a substantial economic burden. In patients with type 2 diabetes, maintaining HbA1c about 1 percentage point lower with intensive glucose control for several years leads to lasting clinical benefits. The current study aims to determine, despite the potential role of diabetes mellitus in cerebrovascular events (ischemic stroke), which HbA1c cut-off increased the risk of cerebrovascular events and which cut-off is safe in terms of cerebrovascular events. This study had been designed with a fucose on HBA1c cut-off point determination compatible with significant increased risk and incidence for ischemic cerebrovascular attacks in diabetes. Methods and Materials Diabetic patients of more than 18 years old who had clinical symptoms and signs of an acute ischemic stroke in recent 6 hours which have been confirmed subsequently by cranial neuroimaging of Computed Tomography Scan or Magnetic Resonance Imaging by an emergency medicine specialist or a neurologist, were included in the study, while diabetic patients with no history of stroke were considered the control group. Serum HbA1c level has been evaluated for both groups. Data has been analyzed to evaluate correlation of serum HbA1c level cut-off with risk of cerebrovascular ischemic stroke in diabetics. Sample size with a power of 80% was calculated 62 diabetic patients with acute ischemic stroke and 62 diabetic patients without stroke as control group. Results Demographic and baseline characteristics of both the case and control groups were compared. There were no significant differences between the two groups in age, sex, IHD, HTN, DLP, and smoking. We had 62 diabetic patients with CVA with a mean age of 64.16±12.43 and 62 diabetic patients without CVA with a mean age of 63.37±6.82. Regarding comparing the HbA1C average between patients with and without CVA, the mean in patients with CVA was 8.21 ±1.70, while in patients without CVA it was 7.56 ±1.28 that which was significantly higher in CVA (p-value <0.02). Using logistic regression, the odds ratio (OR) with a 95% confidence interval was calculated as 1.34 (1.05,1.71). The predictive value of HbA1c for an increase in the risk of CVA occurrence was determined by ROC curve plotting; an AUC with 95% CI (0.516,0.694) was calculated 0.608 (p-value<0.036). Youden index for optimal HbA1c range for CVA risk, considering sensitivity as 69.35 and specificity as 35.48; showed a HbA1c cut-off point of 6.8. Discussion Several studies have assessed differences in mean HbA1c levels between individuals with and without stroke, but the findings have been inconsistent. In addition, only a few studies have demonstrated the predictive value of HbA1c for stroke or identified the specific levels that put patients at higher risk. In this study, we show that the HbA1c mean in diabetic patients with stroke was significantly higher than diabetic patients without stroke. Having diabetes substantially increased the odds of ischemic stroke roughly in the range of 30%to 100% higher risk after adjusting for other vascular risk factors. In a trial, patients with HbA1c8.6% faced increased risk, indicating that lifestyle intervention’s vascular benefits including ischemic stroke prevention are limited to patients with relatively well controlled baseline glycemia. Our study shows that higher HbA1c levels are associated with a raised risk of stroke. Recognizing the HbA1c level that puts patients at higher risk of stroke can help clinicians focus on better glycemic control. Therefore, keeping HbA1c within safe ranges may play an important role in preventing strokes. Conclusion Elevated HbA1c levels exceeding 8% among diabetic patients appear to significantly cause prominent elevation in ischemic stroke occurrence risk, whereas maintaining HbA1c within the 6.8 to 7.0% range accompany with less potential risk for ischemic stroke events.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Parenteral sodium valproate and dexamethasone efficacy evaluation for alleviating migraine headache. (A randomized, controlled, double-blind study)
Introduction. Treating acute migraine headaches in emergency rooms remains a challenge. This study aimed to clarify sodium valproate’s effectiveness in improving acute migraine headaches without aura in the emergency department Material and methods. Selected from emergency room patients with moderate to severe migraine (VAS ≥4), 108 individuals aged 18—60 and weighing 50—85 kg were randomly assigned to two groups: one received 1200 mg sodium valproate, and the other received 8 mg dexamethasone intravenously in 150 ml of normal saline over 10 minutes. The primary outcome compared headache scores before and 1—2 hours after intervention, as well as the percentage of patients headache-free at 2 and 24 hours post-intervention. Results. In the intervention group, headache scores reduced to 2.33±1.74 at 1 hour and 3.49±2.56 at 2 hours after intervention. In the control group, reductions were 2.20±1.86 at 1 hour and 3.30±2.45 at 2 hours. There was no statistically significant difference between the groups. Secondary outcomes showed similar percentages of patients not needing additional pain relief in both groups. Conclusion. Intravenous sodium valproate (1200 mg) did not significantly differ in its effectiveness from intravenous dexamethasone (8 mg) in improving acute migraine headaches without aura.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Parenteral sodium valproate and dexamethasone efficacy evaluation for alleviating migraine headache. (A randomized, controlled, double-blind study)
Introduction. Treating acute migraine headaches in emergency rooms remains a challenge. This study aimed to clarify sodium valproate’s effectiveness in improving acute migraine headaches without aura in the emergency department Material and methods. Selected from emergency room patients with moderate to severe migraine (VAS ≥4), 108 individuals aged 18—60 and weighing 50—85 kg were randomly assigned to two groups: one received 1200 mg sodium valproate, and the other received 8 mg dexamethasone intravenously in 150 ml of normal saline over 10 minutes. The primary outcome compared headache scores before and 1—2 hours after intervention, as well as the percentage of patients headache-free at 2 and 24 hours post-intervention. Results. In the intervention group, headache scores reduced to 2.33±1.74 at 1 hour and 3.49±2.56 at 2 hours after intervention. In the control group, reductions were 2.20±1.86 at 1 hour and 3.30±2.45 at 2 hours. There was no statistically significant difference between the groups. Secondary outcomes showed similar percentages of patients not needing additional pain relief in both groups. Conclusion. Intravenous sodium valproate (1200 mg) did not significantly differ in its effectiveness from intravenous dexamethasone (8 mg) in improving acute migraine headaches without aura.
- Open Access
- 21 March 2023
- Published by Apex Publishing in Jundishapur Scientific Medical Journal
- Vol. 22 (1) , 31-45
A Comparative Study of the Viewpoints of Interns and First-year Specialist Assistants Regarding the Causes and Disclosure of Medical Errors in the Teaching Hospitals of Jundishapur University of Medical Sciences, Ahvaz, in 2018-2019
خطای پزشکی رویداد زیانبار و ناخواستهای است که به صورت بالقوه میتواند باعث ایجاد عوارض و وقوع مرگو میر بیماران شود. این مسئله با پایبندی به استانداردهای پزشکی سختگیرانه، میتواند قابل پیشگیری باشد. جمعآوریدادهها از سطح آگاهی کارکنان درمانی میتواند پنجرهای به افزایش سطح استاندارد خدمات و محدود کردن وقوع خطاهایپزشکی باشد.روش بررسی مطالعه حاضر از نوع اپیدمیولوژیک توصیفی – تحلیلی و مقطعی بود که با هدف تعیین دیدگاه 300 نفر ازکارورزان و دستیاران تخصصی سال اول نسبت به علل و اظهار خطاهای پزشکی در بیمارستانهای آموزشی دانشگاه علومپزشکی اهواز در سال 1398 - 1397 انجام شد و دادهها تجزیه و تحلیل شدند.یافته ها میانگین نمره خطای پزشکی در کارورزان به تفکیک حیطههای مورد بررسی در حد متوسط بود. بین دستیاران باکارورزان بر اساس شیوع خطای پزشکی به علت ویژگیهای خاص هر بیمار و بیماری رابطه معنادار وجود داشت ) 008 / 0 =p ( . نگرش کارورزان و دستیاران نسبت به علل ارتکاب خطای پزشکی در حد متوسط بود. بین دستیاران با کارورزان بر اساسنگرش کلی به دلایل خطاهای پزشکی رابطه معنادار وجود نداشت ) 05 / 0 < p . )نتیجه گیری بر اساس نتایج به دست آمده از این مطالعه شایعترین علت بروز...
- 21 March 2023
- Published by Apex Publishing in Jundishapur Scientific Medical Journal
- Vol. 22 (1) , 31-45
Open AccessA Comparative Study of the Viewpoints of Interns and First-year Specialist Assistants Regarding the Causes and Disclosure of Medical Errors in the Teaching Hospitals of Jundishapur University of Medical Sciences, Ahvaz, in 2018-2019
خطای پزشکی رویداد زیانبار و ناخواستهای است که به صورت بالقوه میتواند باعث ایجاد عوارض و وقوع مرگو میر بیماران شود. این مسئله با پایبندی به استانداردهای پزشکی سختگیرانه، میتواند قابل پیشگیری باشد. جمعآوریدادهها از سطح آگاهی کارکنان درمانی میتواند پنجرهای به افزایش سطح استاندارد خدمات و محدود کردن وقوع خطاهایپزشکی باشد.روش بررسی مطالعه حاضر از نوع اپیدمیولوژیک توصیفی – تحلیلی و مقطعی بود که با هدف تعیین دیدگاه 300 نفر ازکارورزان و دستیاران تخصصی سال اول نسبت به علل و اظهار خطاهای پزشکی در بیمارستانهای آموزشی دانشگاه علومپزشکی اهواز در سال 1398 - 1397 انجام شد و دادهها تجزیه و تحلیل شدند.یافته ها میانگین نمره خطای پزشکی در کارورزان به تفکیک حیطههای مورد بررسی در حد متوسط بود. بین دستیاران باکارورزان بر اساس شیوع خطای پزشکی به علت ویژگیهای خاص هر بیمار و بیماری رابطه معنادار وجود داشت ) 008 / 0 =p ( . نگرش کارورزان و دستیاران نسبت به علل ارتکاب خطای پزشکی در حد متوسط بود. بین دستیاران با کارورزان بر اساسنگرش کلی به دلایل خطاهای پزشکی رابطه معنادار وجود نداشت ) 05 / 0 < p . )نتیجه گیری بر اساس نتایج به دست آمده از این مطالعه شایعترین علت بروز...
- Open Access
- 28 June 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 11 (2) , e10455
A comparison of magnesium sulfate plus morphine with morphine alone for acute pain reduction in long-bone fractures; a double blind randomized clinical trial
Introduction: Acute pain is a common symptom in patients with bone fractures referring to the emergency department (ED). Objectives: The present study aimed at evaluating the efficacy of intravenous (IV) magnesium sulfate in controlling acute pain of long-bone fractures in EDs. Patients and Methods: The present double-blind, randomized clinical trial was conducted on patients with isolated limb fractures referred to Golestan hospital of Ahvaz from 2019 to 2020. Patients in the intervention group were injected with 0.1 mg/kg morphine plus 30 mg/kg magnesium sulfate and 0.1 mg/kg morphine alone in the morphine group. The patient’s pain scores were measured at 0, 15, 30, 45 and 60 minutes after injection. The patients’ condition was monitored every 10 minutes, including respiratory and pulse rate, blood pressure, and knee reflex. Results: The present study was conducted on 64 patients with long-bone fractures allocated to two groups of IV morphine plus magnesium sulfate and IV morphine alone (each of 32). The hemodynamic factors and mean body temperature did not significantly change after intervention and had a similar level in both groups. Before the intervention, the mean score of pain was measured in the morphine and magnesium sulfate plus morphine groups using a visual analogue scale. Results which were 8.87±0.83 and 8.93±0.94, respectively, showing no significant differences (P=0.69). After 60 minutes, the pain score reduced considerably in both groups. Conclusion: In the study, magnesium sulfate plus morphine could better reduce pain than morphine alone without influencing the respiratory rate. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (IRCT20190617043913N1; https://en.irct.ir/trial/40370, ethical code# IR.AJUMS.REC.1398.143).
- 28 June 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 11 (2) , e10455
Open AccessA comparison of magnesium sulfate plus morphine with morphine alone for acute pain reduction in long-bone fractures; a double blind randomized clinical trial
Introduction: Acute pain is a common symptom in patients with bone fractures referring to the emergency department (ED). Objectives: The present study aimed at evaluating the efficacy of intravenous (IV) magnesium sulfate in controlling acute pain of long-bone fractures in EDs. Patients and Methods: The present double-blind, randomized clinical trial was conducted on patients with isolated limb fractures referred to Golestan hospital of Ahvaz from 2019 to 2020. Patients in the intervention group were injected with 0.1 mg/kg morphine plus 30 mg/kg magnesium sulfate and 0.1 mg/kg morphine alone in the morphine group. The patient’s pain scores were measured at 0, 15, 30, 45 and 60 minutes after injection. The patients’ condition was monitored every 10 minutes, including respiratory and pulse rate, blood pressure, and knee reflex. Results: The present study was conducted on 64 patients with long-bone fractures allocated to two groups of IV morphine plus magnesium sulfate and IV morphine alone (each of 32). The hemodynamic factors and mean body temperature did not significantly change after intervention and had a similar level in both groups. Before the intervention, the mean score of pain was measured in the morphine and magnesium sulfate plus morphine groups using a visual analogue scale. Results which were 8.87±0.83 and 8.93±0.94, respectively, showing no significant differences (P=0.69). After 60 minutes, the pain score reduced considerably in both groups. Conclusion: In the study, magnesium sulfate plus morphine could better reduce pain than morphine alone without influencing the respiratory rate. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (IRCT20190617043913N1; https://en.irct.ir/trial/40370, ethical code# IR.AJUMS.REC.1398.143).
- 8 June 2022
- Published by Knowledge E DMCC in Journal of Iranian Medical Council
Evaluating Efficacy, Specificity, and Sensitivity of Liver Enzymes Levels for Early Diagnosis of Acute Appendicitis and its Complications
Background: The most common etiology for patients with acute abdominal pain presenting in emergency departments is acute appendicitis. This study aimed to evaluate the effectiveness of liver enzymes in early diagnosis of acute appendicitis and prediction of its complications. Methods: 176 patients with the chief complaint of abdominal pain presented in the emergency departments were enrolled in this study. All included patients underwent standard approach for acute abdomen with target focus for appendicitis. Samples for serum levels of ALT and AST on arrival have been arranged for all included. Patients were evaluated for appendicitis and diagnosis confirmed by histopathology. AST, ALT variables and confirmed diagnosis of acute appendicitis, and related complications have been evaluated for any correlations using Kruskal-Wallis test. Results: Based on the results, 67 simple, 24 complicated appendicitis, and 85 cases of normal appendix were evaluated. The mean AST was significantly different in normal, simple appendicitis, and complicated groups (p=0.019), but the mean ALT failed to show a significant difference. The differential test showed that there was a significant difference between the two appendicitis groups and the normal group in AST (p<0.05), but not between the two appendicitis groups. The p-values of AST and ALT were 0.17 and 0.2, respectively. Conclusion: According to the results of this study, it seems that increased AST may be increased in simple/complicated appendicitis in contrast to normal group, but regarding AUC curve data, AST and ALT fail to have the necessary diagnostic accuracy and efficiency to diagnose acute appendicitis and predict its complications.
- 8 June 2022
- Published by Knowledge E DMCC in Journal of Iranian Medical Council
Evaluating Efficacy, Specificity, and Sensitivity of Liver Enzymes Levels for Early Diagnosis of Acute Appendicitis and its Complications
Background: The most common etiology for patients with acute abdominal pain presenting in emergency departments is acute appendicitis. This study aimed to evaluate the effectiveness of liver enzymes in early diagnosis of acute appendicitis and prediction of its complications. Methods: 176 patients with the chief complaint of abdominal pain presented in the emergency departments were enrolled in this study. All included patients underwent standard approach for acute abdomen with target focus for appendicitis. Samples for serum levels of ALT and AST on arrival have been arranged for all included. Patients were evaluated for appendicitis and diagnosis confirmed by histopathology. AST, ALT variables and confirmed diagnosis of acute appendicitis, and related complications have been evaluated for any correlations using Kruskal-Wallis test. Results: Based on the results, 67 simple, 24 complicated appendicitis, and 85 cases of normal appendix were evaluated. The mean AST was significantly different in normal, simple appendicitis, and complicated groups (p=0.019), but the mean ALT failed to show a significant difference. The differential test showed that there was a significant difference between the two appendicitis groups and the normal group in AST (p<0.05), but not between the two appendicitis groups. The p-values of AST and ALT were 0.17 and 0.2, respectively. Conclusion: According to the results of this study, it seems that increased AST may be increased in simple/complicated appendicitis in contrast to normal group, but regarding AUC curve data, AST and ALT fail to have the necessary diagnostic accuracy and efficiency to diagnose acute appendicitis and predict its complications.
- Open Access
- 24 April 2022
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Evaluating the analgesic and sedative effects of intravenous ketamine versus morphine administration on relieving long/short bone-fracture pain in the upper/ lower limbs; a phase II clinical trial
Introduction: The importance of pain control in patients with limb trauma admitted to emergency departments as well as its complications is among the main concerns in post-emergency care, which contributes to the accelerated improvement of patients’ conditions in a significant manner. Objectives: The present study was to evaluate the analgesic and sedative effects of intravenous (IV) ketamine versus morphine administration on relieving long/short bone-fracture pain in the upper/lower limbs. Patients and Methods: The present study is as a double-blind randomized clinical trial. For this purpose, the effect of ketamine and morphine were initially examined using IV ketamine and morphine administration, respectively, at the doses of 0.4 and 0.1 mg/kg/IV/10 min in patients, aged 18-65 years with limb trauma, and admitted to hospital emergency departments. Afterward, the duration of the analgesic effect, the amount of pain relief, according to the visual analog scale (VAS) outcomes, and the complications for each drug, including apnea, bradycardia, tachycardia, altered level of consciousness, nausea, vomiting, hypertension/hypotension, seizures and disturbed sleep were compared, and then the preferred method was introduced. Results: In this study, 120 patients in total, including 60 cases receiving ketamine and 60 individuals receiving morphine, were recruited. The participants’ age range was between 19 -70 years. The patients’ mean age was 47.04±12.57 years of whom 89 patients (74.2%) were male. The study results indicated that the potency of the low-dose ketamine infusion in relieving pain in patients was comparable to that of morphine. Conclusion: It was concluded that ketamine could be administered as an alternative to IV morphine to reduce long/short bone-fracture pain in the upper/lower limbs. Trial Registration: The trial protocol was authorized by the Iranian Registry of Clinical Trials, (identifier: IRCT20170716035105N3; https://en.irct.ir/trial/26628, ethical code: IR.AJUMS.REC.1396.248).
- 24 April 2022
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Open AccessEvaluating the analgesic and sedative effects of intravenous ketamine versus morphine administration on relieving long/short bone-fracture pain in the upper/ lower limbs; a phase II clinical trial
Introduction: The importance of pain control in patients with limb trauma admitted to emergency departments as well as its complications is among the main concerns in post-emergency care, which contributes to the accelerated improvement of patients’ conditions in a significant manner. Objectives: The present study was to evaluate the analgesic and sedative effects of intravenous (IV) ketamine versus morphine administration on relieving long/short bone-fracture pain in the upper/lower limbs. Patients and Methods: The present study is as a double-blind randomized clinical trial. For this purpose, the effect of ketamine and morphine were initially examined using IV ketamine and morphine administration, respectively, at the doses of 0.4 and 0.1 mg/kg/IV/10 min in patients, aged 18-65 years with limb trauma, and admitted to hospital emergency departments. Afterward, the duration of the analgesic effect, the amount of pain relief, according to the visual analog scale (VAS) outcomes, and the complications for each drug, including apnea, bradycardia, tachycardia, altered level of consciousness, nausea, vomiting, hypertension/hypotension, seizures and disturbed sleep were compared, and then the preferred method was introduced. Results: In this study, 120 patients in total, including 60 cases receiving ketamine and 60 individuals receiving morphine, were recruited. The participants’ age range was between 19 -70 years. The patients’ mean age was 47.04±12.57 years of whom 89 patients (74.2%) were male. The study results indicated that the potency of the low-dose ketamine infusion in relieving pain in patients was comparable to that of morphine. Conclusion: It was concluded that ketamine could be administered as an alternative to IV morphine to reduce long/short bone-fracture pain in the upper/lower limbs. Trial Registration: The trial protocol was authorized by the Iranian Registry of Clinical Trials, (identifier: IRCT20170716035105N3; https://en.irct.ir/trial/26628, ethical code: IR.AJUMS.REC.1396.248).
- Open Access
- 27 January 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (1) , 37-48
Efficacy Evaluation of Budesonide Nebulizer as an Adjunctive Medication in Post-Rain Asthma Acute Phase Attack
Introduction: Bronchospasm attacks occur following syndromic rainfall and are increasing due to air pollution and need effective treatments. In this study, the effect of salbutamol nebulizer in comparison with salbutamol plus budesonide nebulizer in patients referred to the emergency department with dyspnea was investigated. Material and Methods: The trial study was conducted on 228 patients with dyspnea after the first rainfall in Ahvaz. Two groups of 114 patients have been randomly allocated. On the course of treatment, the first group received salbutamol plus budesonide nebulizer and the second group received salbutamol alone. In the experimental group, budesonide 0.5 mg with salbutamol was nebulized three times for 20 min. In all patients, 20, 40, and 60 min after the start of the intervention, forced expiratory volume in 1 s (FEV1) and peak expiratory flow rate (PEFR) and vital signs of size were recorded and analyzed by SPSS and t-test. Results: Data revealed that there were significant differences between PEFR parameters of studied. Groups in minute 40 and 60 after intervention (p = 0.000001). There was better improvement.in PEFR values in minute 40 and 60 in budesonide plus salbutamol study group. There were no significant differences for FEV1 in minute 0, 20, 40, 60 between to studied group. Also there were no significant differences for borg dyspnea scale for minute 0 and 60 between two experimented group. Respiratory rates have significant differences in minutes 20, 40 after intervention and there was better improvement for salbutamol plus budesonide group rather than sulbutamol intervention group alone. (p = 0.001142). Conclusion: Experiment data revealed. that due to the significant difference between PEFR and increased FEV1 in the combination of the two drugs and due to the corticosteroid effects of budesonide in reducing and preventing inflammation and swelling of the lungs, nebulizer salbutamol + budesonide has better effects on moderate breath than in nebulizer salbutamol.
- 27 January 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (1) , 37-48
Open AccessEfficacy Evaluation of Budesonide Nebulizer as an Adjunctive Medication in Post-Rain Asthma Acute Phase Attack
Introduction: Bronchospasm attacks occur following syndromic rainfall and are increasing due to air pollution and need effective treatments. In this study, the effect of salbutamol nebulizer in comparison with salbutamol plus budesonide nebulizer in patients referred to the emergency department with dyspnea was investigated. Material and Methods: The trial study was conducted on 228 patients with dyspnea after the first rainfall in Ahvaz. Two groups of 114 patients have been randomly allocated. On the course of treatment, the first group received salbutamol plus budesonide nebulizer and the second group received salbutamol alone. In the experimental group, budesonide 0.5 mg with salbutamol was nebulized three times for 20 min. In all patients, 20, 40, and 60 min after the start of the intervention, forced expiratory volume in 1 s (FEV1) and peak expiratory flow rate (PEFR) and vital signs of size were recorded and analyzed by SPSS and t-test. Results: Data revealed that there were significant differences between PEFR parameters of studied. Groups in minute 40 and 60 after intervention (p = 0.000001). There was better improvement.in PEFR values in minute 40 and 60 in budesonide plus salbutamol study group. There were no significant differences for FEV1 in minute 0, 20, 40, 60 between to studied group. Also there were no significant differences for borg dyspnea scale for minute 0 and 60 between two experimented group. Respiratory rates have significant differences in minutes 20, 40 after intervention and there was better improvement for salbutamol plus budesonide group rather than sulbutamol intervention group alone. (p = 0.001142). Conclusion: Experiment data revealed. that due to the significant difference between PEFR and increased FEV1 in the combination of the two drugs and due to the corticosteroid effects of budesonide in reducing and preventing inflammation and swelling of the lungs, nebulizer salbutamol + budesonide has better effects on moderate breath than in nebulizer salbutamol.
- Open Access
- 27 January 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (1) , 86-93
The Effect of Albuterol with Heliox versus Albuterol Nebulization in Acute Asthma Exacerbation: A Randomized Controlled Clinical Trial
Introduction: Asthma is one of the most common chronic disorders of the respiratory tract. Thus, this study intended to evaluate the clinical effects and the peak flow metric effects of nebulized albuterol with heliox versus albuterol nebulization in acute asthma exacerbation. Material and Methods: In this randomized clinical trial study, 109 patients with acute asthma attacks admitted to the emergency departments (EDs) in *** were enrolled. The patients were divided randomly into two groups: the intervention and control groups. The intervention group was nebulized with heliox (helium/oxygen-70: 30) plus albuterol with a 10 mL/min dose for 20 min three times, which lasted 60 min. The control group received standard treatment (albuterol in combination with oxygen). Results: The results showed that the mean scores of FEV1 and PEFR after 20 min were significantly different in the two groups, as FEV1 scores in the intervention group were 2.76 and 3.01 at 20 and 60 min, respectively, while FEV1 scores in the control group were 1.99 and 2.64, respectively (p < 0.001). In addition, PEFR scores in the intervention group at 20 and 60 min were 299.24 and 310.57, respectively. However, these scores in the control group were 237.98 and 274.56, respectively (p < 0.001). Conclusion: The results showed that the use of heliox in t eating severe asthma attacks could be regarded as a different standard treatment that can lead to significantly better control of asthma attacks in the short term.
- 27 January 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (1) , 86-93
Open AccessThe Effect of Albuterol with Heliox versus Albuterol Nebulization in Acute Asthma Exacerbation: A Randomized Controlled Clinical Trial
Introduction: Asthma is one of the most common chronic disorders of the respiratory tract. Thus, this study intended to evaluate the clinical effects and the peak flow metric effects of nebulized albuterol with heliox versus albuterol nebulization in acute asthma exacerbation. Material and Methods: In this randomized clinical trial study, 109 patients with acute asthma attacks admitted to the emergency departments (EDs) in *** were enrolled. The patients were divided randomly into two groups: the intervention and control groups. The intervention group was nebulized with heliox (helium/oxygen-70: 30) plus albuterol with a 10 mL/min dose for 20 min three times, which lasted 60 min. The control group received standard treatment (albuterol in combination with oxygen). Results: The results showed that the mean scores of FEV1 and PEFR after 20 min were significantly different in the two groups, as FEV1 scores in the intervention group were 2.76 and 3.01 at 20 and 60 min, respectively, while FEV1 scores in the control group were 1.99 and 2.64, respectively (p < 0.001). In addition, PEFR scores in the intervention group at 20 and 60 min were 299.24 and 310.57, respectively. However, these scores in the control group were 237.98 and 274.56, respectively (p < 0.001). Conclusion: The results showed that the use of heliox in t eating severe asthma attacks could be regarded as a different standard treatment that can lead to significantly better control of asthma attacks in the short term.
- 1 January 2022
- Published by Yerevan State Medical University in THE NEW ARMENIAN MEDICAL JOURNAL
- Vol. 16 (2) , 76-90
Hospital Admissions Due to Short-term Exposure to Air Pollution: A scoping review
- 1 January 2022
- Published by Yerevan State Medical University in THE NEW ARMENIAN MEDICAL JOURNAL
- Vol. 16 (2) , 76-90
Hospital Admissions Due to Short-term Exposure to Air Pollution: A scoping review